MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 357 filers reported holding MEDIVATION INC in Q4 2015. The put-call ratio across all filers is 0.48 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $6,087,000 | +275.5% | 100,939 | +186.3% | 0.01% | +250.0% |
| Q1 2016 | $1,621,000 | -12.1% | 35,262 | -7.5% | 0.00% | 0.0% |
| Q4 2015 | $1,844,000 | +22.9% | 38,138 | +8.0% | 0.00% | 0.0% |
| Q3 2015 | $1,500,000 | -23.3% | 35,302 | +106.2% | 0.00% | 0.0% |
| Q2 2015 | $1,955,000 | +3.6% | 17,118 | +17.1% | 0.00% | 0.0% |
| Q1 2015 | $1,887,000 | +20.3% | 14,614 | -7.2% | 0.00% | 0.0% |
| Q4 2014 | $1,568,000 | -78.1% | 15,745 | -78.3% | 0.00% | -75.0% |
| Q3 2014 | $7,160,000 | +937.7% | 72,415 | +709.1% | 0.01% | +700.0% |
| Q2 2014 | $690,000 | +19.8% | 8,950 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $576,000 | +4.3% | 8,950 | +3.4% | 0.00% | 0.0% |
| Q4 2013 | $552,000 | -70.9% | 8,655 | -72.7% | 0.00% | -66.7% |
| Q3 2013 | $1,898,000 | +39.5% | 31,659 | +14.5% | 0.00% | +50.0% |
| Q2 2013 | $1,361,000 | – | 27,650 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 2,484,101 | $148,897,000 | 79.45% |
| BB BIOTECH AG | 1,449,706 | $86,895,000 | 4.73% |
| SECTORAL ASSET MANAGEMENT INC | 1,013,529 | $60,751,000 | 2.92% |
| Orbimed Advisors | 2,284,500 | $136,933,000 | 2.44% |
| Archipel Asset Management AB | 191,016 | $11,449,000 | 2.35% |
| BENNETT LAWRENCE MANAGEMENT L L C/NY | 147,060 | $8,815,000 | 1.43% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 450,000 | $26,973,000 | 1.32% |
| QVT Financial LP | 305,128 | $18,289,000 | 1.24% |
| Bain Capital Public Equity Management, LLC | 825,687 | $49,492,000 | 1.24% |
| Tradeworx Inc. | 44,484 | $2,666,000 | 1.22% |